Oxford BioMedica (GB:OXB) has released an update.
Oxford BioMedica PLC has announced a change in their major holdings, with Vitruvian Partners LLP crossing a threshold in voting rights on June 19, 2024. The change resulted in Vitruvian Partners holding 2.85% of voting rights, a slight decrease from their previous position. The notice emphasizes the significance of Vitruvian Investment Partnership III’s role, managed by Vitruvian Partners, as the ultimate owner of the shares.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.
